50461-49-9

Upstream product

• 1021204-96-5 C₁₇H₁₉NO₃S 

Downstream Products

• 1021202-34-5 N-(2-(2-(4-Hydroxy-4-(thiophen-2-yl)piperidin-1-yl)-2-oxoethoxy)ethyl)-4-methoxy-N,2,6-trimethylphenylsulfonamide 
• 1021202-33-4 1-(4-hydroxy-4-thiophen-2-yl-piperidin-1-yl)-2-[1-(4-methoxy-2,6-dimethyl-phenylsulfonyl)-piperidin-2-ylmethoxy]-ethanone 
• 198334-38-2 4-(thiophen-2-yl)piperidine 

Relevant academic research and scientific papers

Substituted Pyrimidine and Triazine Compounds

Substituted pyrimidine and triazine compounds corresponding to formula I wherein R1, R2, R3, R4a, R4b, R5a, R5b, R7, R8, R9a, R9b, R10, R11, A, a, b, s, t, V, W1, W2 and W3 have defined meanings, pharmaceutical compositions comprising such compounds, a process for preparing such compounds, and the use of such compounds and compositions to treat or inhibit pain and/or other disorders or disease states.

Substituted Sulfonamide Compounds

Substituted sulfonamide compounds with bradykinin receptor (B1R) modulating activity; processes for the preparation thereof, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat or inhibit pain and/or other disorders and/or disease states.

Anti-virally active pyridazinamines

Anti-virally active pyridazinamines, compositions containing the same and methods of treating viral diseases in warm-blooded animals.